Previous 10 | Next 10 |
REDWOOD CITY, Calif. , March 11, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release fourth quarter and annual financial results before market open on Monday, March 16, 2020 . AcelRx management wi...
REDWOOD CITY, Calif. , March 10, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced confirmation tha...
REDWOOD CITY, Calif. , March 6, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement wit...
These Robinhood Penny Stocks Can Be Bought For Under $2 But Are They On Your Buy or Sell List Right Now? When it comes to selling or buying penny stocks you likely need a reason, right? Obviously, the short answer is that if you buy, you think a stock will go up. If you sell you either think...
AcelRx Pharmaceuticals (NASDAQ: ACRX ) provides an update on its business and DSUVIA launch metrics. More news on: AcelRx Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
REDWOOD CITY, Calif. , Jan. 13, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today provided an update on its ...
I have covered AcelRx Pharmaceuticals ( ACRX ) previously, so investors should view this as an update to my earlier article on the company. In this article I will focus on the prospects of DSUVIA and Zalviso as a product – I believe the market potential is still underestimated...
REDWOOD CITY, Calif. , Nov. 13, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced a publication analyzing p...
Alexion Pharmaceuticals (NASDAQ: ALXN ) initiated with Buy rating and $125 (15% upside) price target at SunTrust. More news on: Alexion Pharmaceuticals, Inc., Amgen Inc., Arcus Biosciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
AcelRx Pharmaceuticals (NASDAQ: ACRX ) downgraded to Neutral with a $2 (3% upside) price target at Credit Suisse. Shares down 3% premarket. More news on: AcelRx Pharmaceuticals, Inc., CytomX Therapeutics, Inc., Wright Medical Group N.V., Healthcare stocks news, Stocks on the mo...
News, Short Squeeze, Breakout and More Instantly...
AcelRx Pharmaceuticals Inc. Company Name:
ACRX Stock Symbol:
NASDAQ Market:
AcelRx Pharmaceuticals Inc. Website:
AcelRx Announces Rebranding With Name Change to Talphera, Inc. PR Newswire Name change to "Talphera" reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised settings Talphera will begin trading on ...
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States PR Newswire Use of CRRT increased during COVID and remained at these higher utilization levels Study results demonst...
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update PR Newswire Niyad™ Investigational Device Exemption (IDE) approval by the FDA achieved in third quarter Company plans to begin its Niyad registrational study this quarter with topl...